| CD44-antibody-PEG-AuNPs |
Nanocages |
58.4 |
CW 808 nm, 2.5 W cm−2
|
4T1 cells |
24 h |
124
|
| Au-Ur@DTTC |
Spherical |
72.0 |
808 nm, 150 mW |
SKOV3 and CT26 tumor |
24 h |
125
|
| HAuNP@DTTC |
Hollow sphere |
85.0 |
808 nm |
4T1 cells |
24 h |
126
|
| MnO2@Au nanoenvelope |
Spherical |
150.0 |
808 nm, 0.25 W |
PANC-1 and WI-38 cells |
4 h |
127
|
| Ag@CuS NPs |
Spherical |
— |
940 nm |
HeLa cells |
— |
128
|
| HA-4-ATP-AuNFs-DOX |
Nanoframeworks |
140.2 ± 3.2 |
1064 nm, NIR-II laser, 1 W cm−2
|
MDA-MB-231 breast cancer cells |
2 h |
129
|
| AuNR-AS1411, AuNR-MUC1 (bioorthogonal SERS nanotags) |
Nanorods |
50.0 in length and 13.0 in width |
808 nm, NIR laser, 0.2 W |
MCF-7 breast cancer cells |
4 h |
130
|
| Au@PB NPs |
Spherical |
72.0 |
808 nm laser, 2.0 W cm−2
|
4T1 mammary carcinoma cells |
24 h |
131
|
| Nanoenvelope (ISQ@BSAAuNC@AuNR@DAC@DR5) |
Nanorods |
∼30.0 in length and ∼10.0 in width |
808 nm |
A375 human melanoma cells |
— |
132
|
| Au nanostars (Au-4MBA-RGD) |
Nanostars |
295.4 ± 14.8 |
785 nm NIR-I laser, 390 mW cm−2, 1064 nm NIR-II laser, 1160 mW cm−2
|
A549 human lung adenocarcinoma cells |
— |
133
|
| Aptamer-conjugated Au nanocage/SiO2
|
Regular cubic geometry |
Outer edge length: ∼29, wall thickness: ∼3.5, slight corner truncation, and tiny pores on the side face |
785 and 808 nm laser, 1.5 W cm−2
|
MCF-7 breast cancer cells |
24 h |
134
|
| Au@Cu2−xS core–shell NPs |
Hexagonal Cu2−xS (x = 1) (008) and face-centered cubic (fcc) Au |
85.87 ± 10 |
808 nm laser, 0.45 W cm−2
|
HeLa cells and 4T1 cells |
24 h |
135
|
| GNS-L/GB |
Shells |
85.0 |
808 nm laser, 4 W cm−2
|
MIA PaCa-2 and PANC-1 cells |
48 h |
136
|
| Glu-AuNP |
Sphere |
16.0 |
X-radiation, 100 kVp, 10 Gy |
MCF-7 |
2 h |
137
|